ALBIREO PHARMA INC's ticker is ALBO and the CUSIP is 01345P106. A total of 5 filers reported holding ALBIREO PHARMA INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $57,677 | +22.7% | 2,669 | +9.0% | 0.00% | – |
| Q3 2022 | $47,000 | -7.8% | 2,449 | -5.2% | 0.00% | – |
| Q2 2022 | $51,000 | -8.9% | 2,583 | +38.4% | 0.00% | – |
| Q1 2022 | $56,000 | +27.3% | 1,867 | -2.3% | 0.00% | – |
| Q4 2021 | $44,000 | -25.4% | 1,911 | 0.0% | 0.00% | – |
| Q3 2021 | $59,000 | -15.7% | 1,911 | -3.3% | 0.00% | – |
| Q2 2021 | $70,000 | -1.4% | 1,976 | -1.9% | 0.00% | – |
| Q1 2021 | $71,000 | -11.2% | 2,014 | -5.5% | 0.00% | – |
| Q4 2020 | $80,000 | +27.0% | 2,132 | +11.9% | 0.00% | – |
| Q3 2020 | $63,000 | +2000.0% | 1,905 | +1786.1% | 0.00% | – |
| Q2 2020 | $3,000 | – | 101 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Prosight Management, LP | 514,082 | $11,973,000 | 7.17% |
| Privium Fund Management B.V. | 379,117 | $8,959,000 | 1.78% |
| Birchview Capital, LP | 113,000 | $2,632,000 | 1.70% |
| Sio Capital Management, LLC | 213,913 | $4,982,000 | 1.50% |
| Perceptive Advisors | 4,720,278 | $109,936,000 | 0.85% |
| Chicago Capital, LLC | 849,239 | $19,779,000 | 0.74% |
| APOGEM CAPITAL LLC | 38,601 | $899,000 | 0.59% |
| Samsara BioCapital, LLC | 100,000 | $2,329,000 | 0.45% |
| Artal Group S.A. | 600,000 | $13,974,000 | 0.38% |
| RICE HALL JAMES & ASSOCIATES, LLC | 458,011 | $10,667,000 | 0.38% |